We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

185 hedge funds and large institutions have $4.6B invested in Alnylam Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 62 increasing their positions, 69 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 3 → 9 (+6)

25% more capital invested

Capital invested by funds: $3.68B → $4.6B (+$922M)

1% more call options, than puts

Call options by funds: $49.7M | Put options by funds: $49M

4% less funds holding

Funds holding: 193 → 185 (-8)

10% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 69

19% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 26

Holders
185
Holders Change
-8
Holders Change %
-4.15%
% of All Funds
5.37%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.26%
New
21
Increased
62
Reduced
69
Closed
26
Calls
$49.7M
Puts
$49M
Net Calls
+$667K
Net Calls Change
+$5.07M

Top Buyers

1
1WCM
12 West Capital Management
New York
+$42M
2
Ameriprise
Ameriprise
Minnesota
+$22.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$21M
4
AAMU
Amundi Asset Management US
Massachusetts
+$20.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$19.8M

Top Sellers

1
Norges Bank
Norges Bank
Norway
-$32.8M
2
Northern Trust
Northern Trust
Illinois
-$25M
3
Franklin Resources
Franklin Resources
California
-$17.9M
4
CWAM
Columbia Wanger Asset Management
Illinois
-$14.9M
5
CCI
Columbus Circle Investors
-$9.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$39.7M -$32.8M -508,130 -50%
JP Morgan Chase
27
JP Morgan Chase
New York
$39.4M -$341K -5,289 -1%
Ameriprise
28
Ameriprise
Minnesota
$34.3M +$22.9M +354,342 +421%
GTP
29
Global Thematic Partners
New York
$32M -$259K -4,022 -1%
TCM
30
TimesSquare Capital Management
New York
$27.7M -$2.32M -35,900 -9%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$25.8M +$362K +5,617 +2%
AAMU
32
Amundi Asset Management US
Massachusetts
$25.3M +$20.9M +324,287 New
EA
33
Emerald Advisers
Pennsylvania
$23.6M -$576K -8,927 -3%
AG
34
Artal Group
Luxembourg
$23.4M – – –
Northern Trust
35
Northern Trust
Illinois
$21.6M -$25M -387,344 -58%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$21M +$151K +2,337 +0.9%
Citadel Advisors
37
Citadel Advisors
Florida
$19.6M +$16.1M +249,369 +12,588%
ACH
38
ArrowMark Colorado Holdings
Colorado
$17.3M -$2.48M -38,374 -15%
BNP Paribas Asset Management
39
BNP Paribas Asset Management
France
$17.1M +$1.23M +19,145 +10%
EMFAT
40
Emerald Mutual Fund Advisers Trust
Pennsylvania
$16.5M -$704K -10,914 -5%
N
41
Nuveen
North Carolina
$15.9M +$1.83M +28,348 +16%
Deutsche Bank
42
Deutsche Bank
Germany
$13.7M +$452K +7,006 +4%
CS
43
Credit Suisse
Switzerland
$13.4M -$1.6M -24,846 -13%
FC
44
FIC Capital
New York
$12.3M +$326K +5,060 +3%
TRSOTSOK
45
Teachers Retirement System of the State of Kentucky
Kentucky
$11.9M -$419K -6,490 -4%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$10.3M -$241K -3,735 -3%
CCM
47
Cadian Capital Management
New York
$9.76M +$4.19M +65,000 +108%
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$9.64M -$490K -7,591 -6%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$9.63M +$128K +1,981 +2%
TCIM
50
TIAA CREF Investment Management
New York
$8.74M -$3.31M -51,260 -31%
1
2
3 4 5

ALNY Hedge Fund Activity: Q3 2014 in Review

185 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q3 2014, worth a combined $4.6B — up 25% from $3.68B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of ALNY and 21 opened new positions — a net loss of 5 holders — while 69 trimmed existing stakes and 62 added.

The largest buyer was 12 West Capital Management, opening a new position worth an estimated $42M. The largest seller was Norges Bank, cutting an estimated $32.8M.

  • 185 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q3 2014, down from 193 in Q2 2014.
  • Funds reported $4.6B of Alnylam Pharmaceuticals stock for Q3 2014, up 25% quarter-over-quarter.
  • 21 funds opened new Alnylam Pharmaceuticals positions in Q3 2014 and 26 closed out, a net change of -5 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q3 2014 was 12 West Capital Management, an estimated $42M added.
  • The largest Alnylam Pharmaceuticals seller in Q3 2014 was Norges Bank, an estimated $32.8M sold.

Based on aggregated 13F filings for Q3 2014.